 Amarin Corporation plc is a global pharmaceutical company focused internationally on commercializing its sole therapeutic, Vascepa. Amarins sole product is Vascepa, an icosapent ethyl-based cardiovascular therapeutic approved by the FDA, EMA, and various other government agencies around the globe for use in P-CVR. 